Business Context and Reporting Period
Company: Simulations Plus, Inc. (SLP)
Filing Type: Form 8-K (Current Report)
Date of Event: June 15, 2026
Reporting Period: This filing reports a specific corporate event rather than a financial period. The Company is a California corporation incorporated in 2026 (per filing date context) with principal executive offices in Research Triangle Park, NC.
Key Financial Metrics
This Form 8-K does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity metrics. The filing is strictly a disclosure of a proposed merger agreement. Investors should refer to the Company's Annual Report on Form 10-K for the fiscal year ended August 31, 2025, or subsequent Quarterly Reports on Form 10-Q for financial data.
Material Changes
- Merger Agreement Execution: On June 16, 2026, the Company announced the execution of an Agreement and Plan of Merger.
- Transaction Structure: SP Evolution BidCo II, LLC ("Merger Sub"), a wholly owned subsidiary of SP Evolution HoldCo II, LLC ("Parent"), an affiliate of Altaris, LLC, will merge with and into Simulations Plus, Inc.
- Surviving Entity: Simulations Plus, Inc. will survive the merger as a wholly owned subsidiary of Parent.
- Regulatory Status: The transaction is subject to stockholder approval and other customary closing conditions. A definitive proxy statement on Schedule 14A will be filed with the SEC.
Guidance, Outlook, and Risks
Management Commentary: The filing states that the Board of Directors approved the Merger based on expected benefits, though specific strategic rationale details are reserved for the upcoming proxy statement.
Forward-Looking Statements: The document contains forward-looking statements regarding the timing, closing, and benefits of the Merger. These are subject to inherent risks and uncertainties.
Key Risks and Contingencies:
- Closing Conditions: Risk that conditions to closing are not satisfied or waived, or that the Merger does not occur.
- Regulatory Approvals: Risk of delays or unexpected conditions in obtaining required regulatory approvals.
- Termination: Risk of termination of the Merger Agreement, potentially requiring the Company to pay a termination fee.
- Competing Proposals: Risk of competing acquisition proposals.
- Operational Distraction: Risk of management diversion from ongoing business operations.
- Personnel and Relationships: Risk to retaining key personnel and maintaining relationships with customers, partners, and suppliers.
- Market Impact: Risk of adverse effects on the market price of common stock or operating results.
- Financing: While Parent's obligation is not subject to a financing condition, there are risks related to obtaining necessary financing.
- Industry Risks: Changes in laws/regulations affecting healthcare, pharmaceuticals, biotechnology, software, AI, data privacy, and cybersecurity.
- Technology Risks: Cybersecurity incidents, data breaches, or system disruptions.
Investor Verification Checklist
- Review the definitive Proxy Statement on Schedule 14A for detailed transaction terms, consideration to stockholders, and voting procedures.
- Verify the specific financial terms of the Merger (e.g., cash/stock consideration per share) once disclosed in the proxy statement.
- Monitor the status of required regulatory approvals and stockholder vote results.
- Assess the potential for termination fees and their impact on the Company's balance sheet if the deal fails.
- Review the Company's most recent Form 10-K (filed December 1, 2025) for baseline financial health prior to the merger announcement.